Novel method for stabilizing nucleic acid nanostructures
AssigneeTechnische Universität München
InventorsThomas Gerling, Hendrik Dietz
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel method for stabilizing nucleic acid nanostructures by curing with ultraviolet light, particularly by crosslinking pyrimidine nucleotides.
Claims34
A method for increasing the stability of a non-naturally occurring nucleic acid nanostructure, wherein said nanostructure comprises at least one single-chain nucleic acid sequence binding to at least two non-contiguous sequence stretches present on one or more complementary nucleic acid sequences, wherein said method is characterized by a step of exposing said nucleic acid nanostructure to UV irradiation, wherein said step of exposing said nucleic acid nanostructure to UV irradiation results in the formation of at least one chemical bond between two pyrimidine nucleotides, wherein at least one of the two pyrimidine nucleotides is not part of a complementary nucleotide pair comprised in a double-helical substructure.
A method for increasing the stability of a non-naturally occurring nucleic acid nanostructure, wherein said nanostructure comprises at least one single-chain nucleic acid sequence binding to at least two non-contiguous sequence stretches present on one or more complementary nucleic acid sequences, wherein said method is characterized by a step of exposing said nucleic acid nanostructure to UV irradiation.
A method for increasing the stability of a non-naturally occurring nucleic acid nanostructure, wherein said nanostructure comprises at least two double-helical substructures, wherein said method is characterized by a step of exposing said nucleic acid nanostructure to UV irradiation.
A method for increasing the stability of a non-naturally occurring nucleic acid nanostructure comprising a multiplicity of double-helical substructures, wherein said nanostructure comprises at least one single-chain nucleic acid sequence being part of at least two different double-helical substructures, wherein said method is characterized by a step of exposing said nucleic acid nanostructure to UV irradiation.
A kit for the generation of a nucleic acid nanostructure comprising one or more copies of at least a first single-stranded polynucleotide, and a set of single-stranded polynucleotides, wherein each of the single-stranded polynucleotides consists of an n-specific sequence consisting of n core sequences, with n being an integer independently selected from the range of 1 to 40, wherein each of said n core sequences consists of (i) a sequence that is complementary to a region on said first single-stranded polynucleotide, wherein the region complementary to the nth core sequence is not contiguous with the regions complementary to the (n−1)th and (n+1)th core sequence, (ii) a pyrimidine nucleotide stretch Pm, at the 3′ end, (iii) a pyrimidine nucleotide stretch Pm at the 5′ end, and (iv) optionally, one or more insertions of a pyrimidine nucleotide stretch Pm, wherein each m is an integer independently selected from the range of 0 to 40, and wherein each P is independently selected from a thymidine and a cytosine residue.
A kit for the generation of a nucleic acid nanostructure comprising a set of single-stranded oligonucleotides,
- wherein each of the single-stranded polynucleotides consists of an n-specific sequence consisting of n core sequences, with n being an integer independently selected from the range of 1 to 40, wherein each of said n core sequences consists of (i) a sequence that is complementary to the sequence of another member of said set of single-stranded polynucleotides, wherein the region on said another member complementary to the nth core sequence is not contiguous with the regions complementary to the (n−1)th and (n+1)th core sequence, (ii) a pyrimidine nucleotide stretch Pm, at the 3′ end, (iii) a pyrimidine nucleotide stretch Pm at the 5′ end, and (iv) optionally, one or more insertions of a pyrimidine nucleotide stretch Pm,
- wherein each m is an integer independently selected from the range of 0 to 40, and wherein each P is independently selected from a thymidine and a cytosine residue.
A nucleic acid nanostructure comprising one or more copies of at least a first single-stranded polynucleotide, and a set of single-stranded polynucleotides, wherein each of the single-stranded polynucleotides consists of an n-specific sequence consisting of n core sequences, with n being an integer selected from the range of 1 to 40, wherein each of said n core sequences consists of (i) a sequence that is complementary to a region on said first single-stranded polynucleotide, wherein the region complementary to the nth core sequence is not contiguous with the regions complementary to the (n−1)th and (n+1)th core sequence, (ii) a pyrimidine nucleotide stretch Pm, at the 3′ end, (iii) a pyrimidine nucleotide stretch Pm at the 5′ end, and (iv) optionally, one or more insertions of a pyrimidine nucleotide stretch Pm, wherein each m is an integer independently selected from the range of 0 to 40, and wherein each P is independently selected from a thymidine and a cytosine residue.
A nucleic acid nanostructure comprising a set of single-stranded oligonucleotides, wherein each of the single-stranded polynucleotides consists of an n-specific sequence consisting of n core sequences, with n being independently selected from the range of 1 to 40, wherein each of said n core sequences consists of (i) a sequence that is complementary to the sequence of another member of said set of single-stranded polynucleotides, wherein the region on said another member complementary to the nth core sequence is not contiguous with the regions complementary to the (n−1)th and (n+1)th core sequence, (ii) a pyrimidine nucleotide stretch Pm, at the 3′ end, (iii) a pyrimidine nucleotide stretch Pm at the 5′ end, and (iv) optionally, one or more insertions of a pyrimidine nucleotide stretch Pm, wherein each m is an integer independently selected from the range of 0 to 40, and wherein each P is independently selected from a thymidine and a cytosine residue.
Dependencies are inferred from the claim text.